Abby Markeson splits her practice between Hatch-Waxman litigation and related strategic counseling and patent due diligence investigations for major biopharma transactions. She has litigated patents covering numerous blockbuster drugs and advised clients in USPTO contested proceedings. Informed by her significant litigation experience, Abby counsels clients on patent due diligence for high profile acquisitions and other transactions. Through her work advising innovator pharmaceutical companies, Abby has a deep understanding of the drug discovery process. She has handled cases concerning a broad array of therapeutic areas, including oncology, immunosuppression, GI disorders, infectious diseases, inflammatory conditions, neurological disorders, and kidney disease. Abby previously worked in the New York City office of a national law firm where she advised clients on a variety of patent law matters including litigation, due diligence, freedom-to-operate, USPTO contested proceedings, patent prosecution, mediation, and settlements. Prior to launching her legal career, Abby researched portable sensors to detect chemical warfare agents and treatments for breast cancer. Abby received The Legal Aid Society's Pro Bono Publico Award in 2011 for her work representing low income artists in New York.
Kilpatrick Townsend & Stockton LLP
Firm Prospects attorney tracking launched in 2015/2016. Prior employment history currently unavailable.